Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 19-Sep-24
Select bar for recommendation details.
Recommendations | 19-Sep-24 | |
---|---|---|
Buy | 1 | |
Outperform | 7 | |
Hold | 2 | |
Sell | 1 | |
Strong Sell | 0 |
Share price forecast in SEK
The 10 analysts offering 12 month price targets for Swedish Orphan Biovitrum AB (publ) have a median target of 330.00, with a high estimate of 585.00 and a low estimate of 250.00. The median estimate represents a 1.91% increase from the last price of 323.80.
High | 80.7% | 585.00 |
Med | 1.9% | 330.00 |
Low | -22.8% | 250.00 |
Earnings history & estimates in SEK
The next earnings announcement is expected on Oct 24, 2024.
Average growth rate | +205.64% |
Average growth rate | -5.64% |
More ▼
Revenue history & estimates in SEK
Average growth rate | +4.23% |
Average growth rate | +11.90% |
More ▼